Rare diseases
Investigational molecules
Locations
Evaluation of controlled-ileal-release nicotinic acid tablets compared to placebo for treating people with prediabetes
GermanyStudy of felzartamab compared to placebo in adults with IgA nephropathy
GermanyStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanyStudy of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
GermanyStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
GermanyStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
GermanyStudy of empagliflozin compared to placebo in patients with acute decompensated heart failure who are already taking SGLT2 inhibitors
GermanyStudy of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia
GermanyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
GermanyEvaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression
GermanyStudy of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation
GermanyComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
